Revenue cycle company nThrive, formerly MedAssets-Precyse, announced plans to buy Adreima, an Illinois-based provider of clinically-integrated revenue cycle services, the company announced Wednesday.
Adreima solutions help patients find coverage and meet their financial obligations, while partnering with healthcare providers to optimize revenue cycle functions.
The deal is expected to close before the end of the year, nThrive said in a statement.
"The addition of the Adreima business fortifies the nThrive portfolio with new, strategic capabilities that are essential to evolving industry dynamics, including patient eligibility determination and enrollment services, which improve the ability of health care providers to identify appropriate programs to fund care and assist patients in gaining access....As patients take on a higher portion of financial responsibility for their care, providers increasingly seek to deliver a positive experience as patients work to resolve their financial responsibility," the company said in a statement.
In June, the former MedAssets-Precyse officially unveiled its rebranding as nThrive at the HFMA conference in Las Vegas and announced a new revenue cycle platform that integrated with major electronic health record vendors in hopes of providing a single tool for managing healthcare reimbursement.
The announcement comes one year after Pamplona Capital Management acquired the MedAssets for $2.7 billion and merged it with its own platform, Precyse.
The company also merged nThrive's Equation brand, an analytics and consulting firm, and has partnered with both Epic and Cerner to create a compatible system for claims reconciliation that aims to prevent denials.